You called it as it is my friend. There's is research with a bit of optimistic licence and then there is blatant ramping. It's pretty clear what the company needs and what is happening.
They need $$$
They will need a CR before the FY most likely
CE Mark is still a way off.
Most likely revenue will come from sales of Felix after CE Mark,
There is a small chance that the Brazilian investors come on board as oppose to a CR
We have a small chance of the Equine study get us some revenue early as suggested by David when it was announced
We have the $3 Mill con notes to deal with
R&D funds keep getting spend before they are earn't
They pay themselves like the company is not pre revenue.
Alison sold some shares according to my latest top 20, not many but some.
The only Positive I see currently is our SP is super low and punished, not reflective of our potential. Currently you can buy at .0055 which I just got 1 mill at that price. So if I don't buy seems nobody else does, as i said
MEM Price at posting:
0.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)